• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

J Ind Microbiol Biotechnol 2020 Jul;47(6-7):475-84

A comparison of culture-based, real-time PCR, droplet digital PCR and flow cytometric methods for the detection of Burkholderia cepacia complex in nuclease-free water and antiseptics.

Ahn Y, Gibson B, Williams A, Alusta P, Buzatu DA, Lee YJ, LiPuma JJ, Hussong D, Marasa B, Cerniglia CE

Abstract

The presence of Burkholderia cepacia complex (BCC) strains has resulted in recalls of pharmaceutical products, since these opportunistic pathogens can cause serious infections. Rapid and sensitive diagnostic methods to detect BCC are crucial to determine contamination levels. We evaluated bacterial cultures, real-time PCR (qPCR), droplet digital PCR (ddPCR), and flow cytometry to detect BCC in nuclease-free water, in chlorhexidine gluconate (CHX) and benzalkonium chloride (BZK) solutions. Twenty BCC strains were each suspended (1, 10, 100, and 1000 CFU/ml) in autoclaved nuclease-free water, 10 µg/ml CHX, and 50 µg/ml BZK. Five replicates of each strain were tested at each concentration (20 strains¿×¿4 concentrations¿×¿5 replicates¿=¿400 tests) to detect BCC using the aforementioned four methods. We demonstrated the potential of ddPCR and flow cytometry as more sensitive alternatives to culture-based methods to detect BCC in autoclaved nuclease-free water and antiseptics samples.


Category: Journal Article
PubMed ID: #32671501 DOI: 10.1007/s10295-020-02287-3
Includes FDA Authors from Scientific Area(s): Toxicological Research Drugs
Entry Created: 2020-07-19 Entry Last Modified: 2020-08-02
Feedback
-
-